Pfizer Confirms COVID-19 Pill’s Results, Potency Versus Omicron - a podcast by time.com

WASHINGTON — Pfizer said today that its experimental pill to treat COVID-19 appears effective against the omicron variant.

The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms.

Further episodes of 301 Moved Permanently

Further podcasts by time.com

Website of time.com